Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates. (CERAINE)

March 11, 2026 updated by: Centre Hospitalier Intercommunal Creteil

Criteria and Reasons for Extubation and Non-extubation in Preterm Infants: A Mixed Methods Study Prospectively Exploring Extubation and Reintubation Practices in Extremely Preterm Infants, and Associated Respiratory Outcomes.

The purpose of this observational study is to learn about neonatologists' perceptions of extubation readiness and extubation and reintubation practices in extremely preterm infants in the first 2 weeks of life using prospective qualitative and quantitative data. Actual extubation readiness is defined as successful extubation, defined as no reintubation in the 7 days following extubation.

Key research questions are: How do clinicians assess extubation readiness in this population? Does this assessment correlate with actual extubation success? What factors (reasons, clinical status, ventilatory parameters) are associated with extubation readiness? Patients born before 28 weeks gestational age and admitted to the neonatal intensive care unit (NICU) within the first 24 hours are be included. The attending physician will complete a prospectively administered questionnaire with open-ended and multiple-choice questions to daily assess the decision and rationale for extubation or non-extubation of patients mechanically ventilated during the first 15 days of life.

Patient characteristics, respiratory outcomes, and mortality will be recorded until the end of hospitalisation and/or definitive weaning from any ventilatory support or supplemental oxygen.

Study Overview

Detailed Description

With prolonged stays in the neonatal intensive care unit (NICU) and significant respiratory morbidity, respiratory management of the most premature newborns - born before 28 weeks gestational age (GA) - brings a number of challenges. Despite recommendations to give priority to non-invasive ventilation in cases of respiratory insufficiency, recent studies show that over 80% of these newborns receive mechanical ventilation (MV) at least once in their NICU course, most within the first week of life (100% if born at 23 SA, >90% at 24 and 25 SA, >80% at 26 and >70% at 27 weeks GA). Several studies have shown that a longer cumulative duration of MV is associated with a worse respiratory and neurodevelopmental prognosis in this population.

Early extubation is therefore recommended. However, extubation failures in patients born at these early stages of life are common and are per se associated with respiratory morbidity. Extubation failure is defined in the literature as reintubation within days of extubation.

A delay of 7 days after extubation has been identified as the time frame for capturing extubations related to respiratory causes. In a French study, using the SEPREVEN cohort for patients born before 27 weeks' GA, extubation failure at 3, 7 and 15 days concerned 25%, 33% and 50% of patients respectively. The decision to extubate a premature patient is a complex one, but contributes in part to the patient's outcome.

Shalish referred to the concept of "extubation readiness dilemma" to indicate the uncertainty surrounding the clinical features associated with successful extubation. Identifying a state for each patient that allows successful extubation, without reintubation in the following days, is most often based on ward routines in which assessments of the infant's respiratory capacity are taken into account. Medical literature doesn't provide recommendations on extubation criteria, and practices differ from one unit to another.

The aim of this study is to provide a detailed description of extubation practices and failures in several NICUs in France, based on a prospective collection of qualitative and mixed data.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Amiens, France, 80054
        • Completed
        • Chu Amiens Sud
      • Bayonne, France, 64109
        • Completed
        • CH Côte Basque
      • Besançon, France, 25030
        • Completed
        • CHU de Besancon
      • Brest, France, 26609
      • Bron, France, 69677
        • Completed
        • Hopital Femme Mére Enfant - HFME
      • Cherbourg-Octeville, France, 50102
        • Completed
        • Centre Hospitalier Public du Cotentin
      • Clermont-Ferrand, France, 63 003
        • Completed
        • CH Estaing
      • Colombes, France, 92700
        • Completed
        • CHU Louis Mourier
      • Créteil, France, 94000
        • Completed
        • CHIC
      • Grenoble, France, 38700
        • Completed
        • CHU Grenoble Alpes _site nord
      • La Réunion, France, 97405
        • Completed
        • CHU Felix Guyon
      • Le Kremlin-Bicêtre, France, 94270
        • Completed
        • CHU Kremlin-Bicêtre
      • Le Mans, France, 72037
        • Completed
        • CH Le Mans
      • Lille, France, 75019
        • Completed
        • Chu Lille
      • Limoges, France, 87042
        • Completed
        • HME Limoges
      • Marseille, France, 13915
        • Completed
        • APHM_ Hôpital Nord
      • Meaux, France, 77104
        • Completed
        • GHEF- Site de MEAUX
      • Montreuil, France, 93105
        • Completed
        • CHI André Grégoire
      • Mulhouse, France, 68100
        • Completed
        • GHRMSA-Hopital Emile Muller
      • Nice, France, 06202
        • Completed
        • CHU Nice
      • Nîmes, France, 30000
        • Completed
        • Chu Nimes
      • Orléans, France, 45067
        • Completed
        • CH Orléans
      • Paris, France, 75019
        • Completed
        • CHU Robert Debré
      • Paris, France, 75743
        • Completed
        • CHU Necker
      • Paris, France, 75679
        • Completed
        • Chu Port Royal
      • Poissy, France, 78303
        • Completed
        • CHI Poissy - St Germain en LayE
      • Reims, France, 51100
        • Completed
        • CHU Reims
      • Rennes, France, 35203
        • Completed
        • CHU Rennes
      • Saint-Denis, France, 93205
        • Completed
        • CH General Delafontaine
      • Senlis, France, 60300
        • Completed
        • CH GHPSO
      • Troyes, France, 10000
        • Completed
        • CH Troyes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participation in the study is proposed to type 3 neonatal intensive care units in France. Extremely premature newborns born before 28 weeks gestation in the participating units will be included.

Description

Inclusion Criteria:

  • Gestational age < 28 weeks of gestation
  • Age at admission to the participating unit <24 hours

Exclusion Criteria:

  • Parental opposition to their infant's clinical data collection
  • Participation in a research protocol with potential impact on extubation and/or duration of mechanical ventilation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Extremely Low Gestational Age Newborns (elgans)
No intervention. unique group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reasons for non-extubation in case of MV in patients born before 28 wks GA in the first 15 days of life,
Time Frame: On a 12 hours basis from Day 0 to Day 2 of life, and on a dialy basis from Day 2 to Day 15 of life (according to the period the patient is on Mechanical Ventilation)
For each included patient who is intubated and mechanically ventilated during a period within his first 15 days of life, the reasons for non-extubation. These are the reasons reported by the physician by answering a qualitative questionnaire with an open-ended question, and preexistent possible multiple choices.
On a 12 hours basis from Day 0 to Day 2 of life, and on a dialy basis from Day 2 to Day 15 of life (according to the period the patient is on Mechanical Ventilation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reported perceived extubation readiness in Extremely Low Gestational Age Neonates (ELGANs) born before 28weeks gestation and mechanically ventilated in a period within the first 15 days of life.
Time Frame: These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
Reported perceived extubation readiness in ELGANs born before 28weeks gestation and mechanically ventilated in a period within the first 15 days of life, defined as Reasons for extubation and ventilatory and clinical data,
These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
Occurrence of Extubation failure in ELGANs on Mechanical ventilation within the first 15 days of life.
Time Frame: These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
Occurrence of Extubation failure defined as reintubation in the 7 days after an extubation.
These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
Corrected gestational age on definitive discontinuation of MV, of Positive Pressure Non-Invasive Ventilation (NIV), of High Flow Nasal Cannula (HFNC) ventilation) and Low Flow Nasal Cannula Ventilation (LFNNC)
Time Frame: From the day of birth to 4 months of age.
Corrected gestational age on definitive discontinuation of MV, of Positive Pressure Non-Invasive Ventilation (NIV), of High Flow Nasal Cannula (HFNC) ventilation) and Low Flow Nasal Cannula Ventilation (LFNNC)
From the day of birth to 4 months of age.
Cumulative duration of mechanical ventilation (MV) during the NICU stay.
Time Frame: These data will be collected from the day of birth to the day of discharge from the NICU, up to maximum 4 months of age..
Sum of the days of mechanical ventilation during the NICU stay, collected prospectively.
These data will be collected from the day of birth to the day of discharge from the NICU, up to maximum 4 months of age..
The cumulative duration of any respiratory support
Time Frame: From the day of birth to the day of discharge from the hospital, up to maximum 4 months of age.
The cumulative duration of positive pressure Non-Invasive Ventilation (PPNIV) and High Flow Nasal Ventilation (HFNV), Low Flow Nasal Ventilation (LFNV) during the entire hospital stay
From the day of birth to the day of discharge from the hospital, up to maximum 4 months of age.
Duration of Mechanical Ventilation and Positive Pressure Non-Invasive Ventilation
Time Frame: From the day of birth to the day of discharge from the hospital, up to 4 months of age
Sum of the days of Mechanical Ventilation or positive pressure non invasive ventilation during the entire hospital stay
From the day of birth to the day of discharge from the hospital, up to 4 months of age
Bronchopulmonary dysplasia at 36 weeks corrected Gestational Age
Time Frame: At 36 weeks corrected gestational age
Bronchopulmonary dysplasia at 36 weeks corrected Gestational age defined as need for any type of ventilation (invasive or non-invasive) or low flow oxygen therapy at 36 weeks gestational age.
At 36 weeks corrected gestational age
Mortality
Time Frame: From the day of birth to the day of discharge from the hospital, maximum 5 months of age
Mortality before discharge from the hospital
From the day of birth to the day of discharge from the hospital, maximum 5 months of age
Length of stay in the Neonatal Intensive Care Unit (NICU)
Time Frame: From the day of birth to the day of discharge from the NICU, maximum 4 months of life
Length of stay in the NICU
From the day of birth to the day of discharge from the NICU, maximum 4 months of life
Factors involved in the perception of "too altered respiratory condition to be extubated"
Time Frame: From the day of birth to day 15 of life during the period on Mechanical Ventilation
Description of the reasons related to the respiratory system, clinical respiratory conditions (e;g. apneas ....) and ventilatory settings (pressure, oxygen, ...) reported by the physician associated with a reported "too altered respiratory condition to be extubated" condition.
From the day of birth to day 15 of life during the period on Mechanical Ventilation
Clinician-reported Prognosis of extubation succes
Time Frame: From day of birth to day 15 of life during the period on Mechanical Ventilation
Physician-reported prognosis of extubation based on a 4 points scale (from 1 "unconfident" to 4 "very confident")
From day of birth to day 15 of life during the period on Mechanical Ventilation
Description of complications of intubation
Time Frame: from the day birth to the day discharge from the NICU, up to maximum 4 months of life

Description of a multiple choice of complications after each intubation :

No complication, oropharyngeal lesion, cardiorespiratory arrest, severe intraventricular haemorraghe, contribution to patient's death.

from the day birth to the day discharge from the NICU, up to maximum 4 months of life

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of unit practices (mechanical ventilation weaning protocol and/or extubation criteria in standard care)
Time Frame: From the date of enrollment to the date of the end of the inclusions, which means one year.
Description of unit practices (use of a Mechanical Ventilation weaning protocol and/or the use of extubation criteria in standard care)
From the date of enrollment to the date of the end of the inclusions, which means one year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2025

Primary Completion (Actual)

January 5, 2026

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 30, 2025

First Posted (Actual)

February 5, 2025

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 11, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchopulmonary Dysplasia

Subscribe